课题基金 / 基金详情

COMPREHENSIVE SICKLE CELL CENTER

COMPREHENSIVE SICKLE CELL CENTER
综合性镰状细胞中心
批准号:
3108498
负责人:
SERGIO S PIOMELLI
金额:
$228.87万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-04-01 至 1998-03-31

项目摘要

项目成果

SERGIO S PIOMELLI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Comprehensive Sickle Cell Center of Columbia University includes the scientific resources of the College of Physicians and Surgeons and the clinical resources of its 3 main hospitals: Presbyterian, St. Luke's/Roosevelt and Harlem Hospital. The Center will continue to provide excellent clinical care, screening, genetic counseling, prenatal diagnosis and education to the community of the upper part of Manhattan, where the largest concentration of patients with sickle cell diseases (SCD) and their families live. The Center will include 8 research units, 3 clinical units (one at each hospital) and 2 core units. The research units will be exclusively dedicated to research; the clinical units will also provide clinical care, screening and education. The areas of research will be the following: Transfer of the beta-globin gene, Production and study of transgenic mice containing HgbS, Interactions and aggregation of HgbS molecules, Erythropoietic precursors in SCD, Microvascular function in SCD, Cerebro-vascular circulation in SCD, Neurological involvement in SCD, Bone marrow transplantation in SCD. Two core units will also provide molecular biology analysis, prenatal diagnosis, hematological testing, data management, statistics and administration. The goal of the Center is to foster improved knowledge in the area of sickle cell diseases and to provide an environment where the advances in the field generated by the various research projects may be brought immediately to the patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ORAL FE CHELATORS IN SICKLE CELL DISEASE
ORAL FE CHELATORS IN SICKLE CELL DISEASE
ORAL FE CHELATORS IN SICKLE CELL DISEASE
ORAL FE CHELATORS IN SICKLE CELL DISEASE
海外基金